2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

MS Aapro; J Bohlius; DA Cameron; L Dal Lago; JP Donnelly; N Kearney; GH Lyman; R Pettengell; VC Tjan-Heijnen; J Walewski; DC Weber; C Zielinski

doi:10.1016/j.ejca.2010.10.013

Back

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

Journal article

Peer reviewed

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, GH Lyman, R Pettengell, VC Tjan-Heijnen, J Walewski, …

EUROPEAN JOURNAL OF CANCER, Vol.47(1), pp.8-32

01/01/2011

DOI: https://doi.org/10.1016/j.ejca.2010.10.013

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

Antineoplastic agents

Filgrastim

Granulocyte colony-stimulating factor

Lenograstim

Neoplasms

Neutropenia

Pegfilgrastim

Guideline

CELL LUNG-CANCER

NON-HODGKINS-LYMPHOMA

PHASE-III TRIAL

METASTATIC BREAST-CANCER

MULTICENTER RANDOMIZED-TRIAL

QUALITY-OF-LIFE

ADVANCED OVARIAN-CANCER

HEMATOPOIETIC GROWTH-FACTORS

CHRONIC LYMPHOCYTIC-LEUKEMIA

PACLITAXEL PLUS CARBOPLATIN

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000286774700002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

50 Record Views

826 Times Cited - Web of Science

See more details

Details

Title: 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
Creators: MS Aapro
J Bohlius
DA Cameron
L Dal Lago
JP Donnelly
N Kearney
GH Lyman
R Pettengell
VC Tjan-Heijnen
J Walewski
DC Weber
C Zielinski
Publication Details: EUROPEAN JOURNAL OF CANCER, Vol.47(1), pp.8-32
Publisher: ELSEVIER SCI LTD
Date published: 01/01/2011
Date submitted: 17/05/2017
Identifiers: 99516185902346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

Abstract

Files and links (1)

Metrics

Details

Usage Policy